Projeto
Kyotorphin as new pharmacological therapeutic strategy for Alzheimers Disease
| Referência: | PD/BD/114337/2016 |
|---|---|
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade de Lisboa |
Registos relacionados
Multitarget-directed ligand strategy for Alzheimers disease
Generation of improved cellular and animal models for identification of disease phenotype and new therapeutic targets of Alzheimer’s Disease
Pharmacological Modulators of Parkinsons Disease-Associated Proteins
Preventing Memory Loss in Alzheimer`s Disease: Underlying Mechanisms and Therapeutic Targets of Tauroursodeoxycholic Acid
THE NEUROPEPTIDE KYOTORPHIN AND ITS DERIVATIVES: UNVEILING ROUTES AND TARGETS
THE BIOCHEMICAL FOUNDATIONS OF THE STRONG ANALGESIA OF A NOVEL KYOTORPHIN DERIVATIVE
Adenosine A2A receptors as triggers of memory dysfunction in Alzheimer?s disease: mechanisms and therapeutic propects
Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease
Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease
VISION AND COGNITION IN EARLY ALZHEIMER’S DISEASE: CONTRIBUTION OF NEW DIAGNOSTIC TOOLS FOR NEW CLASSIFICATION CRITERIA
Adenosine receptors: new pharmacological targets for Rett syndrome treatment
BDNF receptor cleavage:relevance for Alzheimer´s Disease pathophysiology
Unravelling the link between Cell Competition and Alzheimer´s Disease
Multifunctional magnetic nanoparticles for targeted Alzheimer´s Disease theranostics
Modulation of BDNF effects by adenosine: a new strategy for schizophrenia treatment - Adenosinergic signaling as a new pharmacological target for schizophrenia treatment
Early Diagnosis of Alzheimer´s Disease: evaluation of recent classification criteria and proposal of new diagnostic tools
Glycans as dual orchestrators of microbiome and immune response in Inflammatory Bowel Disease pathogenesis: impact in new therapeutic strategies
Endosomal damage in Alzheimers Disease [PD/BD/105915/2014]
Decoding the regulation of microglia phenotype by microRNAs in Alzheimer's Disease
Tailor-made foods for the prevention of Alzheimer disease and cognitive decline
INNOVATIVE WATER-SOLUBLE PHYTOMATERIAL INHIBITORs FOR ALZHEIMERs AND PARKINSONs DISEASES PREVENTION
Beyond Beta-Amyloid - Deciphering Early Pathogenic Changes in Alzheimer's disease
Regulation of adenosine levels as a new therapeutic strategy for Rett Syndrome
Bolsa de Doutoramento FCT: MIRNA-29 Bioseparation and Target Delivery Strategies for Alzheimer Disease [SFRH/BD/81914/2011]
Enhanced AAV vector toolkit for the generation of novel animal models and therapeutic strategies for polyglutamine diseases
Genetic Epidemiology of Alzheimers Disease in Hispanics [5R37AG015473-08]
New Edge in the therapeUtics of PaRkinsON´s diSeaSe from SeaweedS
Screening and pharmacological characterization of flavonoids as lead compounds for obesity treatment
Modulation of A-Beta toxicity by transthyretin in Alzheimer's Disease [PTDC/SAU-NEU/64593/2006]
A temporal mining approach for prognostic prediction in Alzheimer´s disease using heterogeneous clinical data
MEMORY STIMULATION IN ALZHEIMER DISEASE: THE ROLE OF SENSECAM COMPLEMENTARY TO A COMPREHENSIVE MEMORY TRAINING PROGRAM
Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia
Dementia and Alzheimer´s Disease in Portugal: from illness narratives to socio-economic costs Determination of Rage and S 100 expression levels on Parkinson s Disease
Development of a Novel Multicellular In Vitro Model of Alzheimer’s disease-<br>like Blood-Brain Barrier
Diagnostic tool for Alzheimer’s disease based on a proprietary blood-brain barrier peptide shuttle-nanoparticle
Analyzing NeuroIMmune dysregulation in Alzheimer´s disease toward a Therapy with miRNA-loaded Exosomes
FROM A MULTITARGET ANTIDIABETIC GLYCOSYL ISOFLAVONE TOWARDS NEW MOLECULAR ENTITIES AGAINST DIABETES AND ALZHEIMERS DISEASE: GENERATION OF LEAD DERIES AND TARGET ASSESSMENT
Shaping the Mechano-Pharmacological properties of Microparticles and Extracellular Vesicles for the Treatment of Osteoarthritis [872648]
Towards the development of a nanoparticle for early diagnosis of Alzheimer’s Disease, based on the reversible translocation of the blood brain barrier.
MICRORNAS-LOADED NANOPARTICLES AS A NEW PROMISING THERAPEUTIC TOOL FOR NEURAL STEM CELL-BASED BRAIN REPAIR STRATEGIES
Publicações relacionadas
Carregando publicações...